Molecular responses continue to deepen with extended treatment duration, reaching 60% major molecular response at 21 cycles ...

Syndax Pharmaceuticals, Inc. ( SNDX) The 67th American Society of Hematology ( ASH) Annual Meeting December 8, 2025 7:00 AM EST ...

Dramatically improved disease control with 21.2 months vs. 2.9 months median event-free survival (EFS) Favorablesafety ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development, and commercialization of novel, ...

Preliminary clinical evidence of Lisaftoclax overcoming venetoclax resistance in myeloid malignancies with a 31.8% overall response rate(ORR) in this subgroup of patients; 80% ORR ...

BioCT, the CT life sciences trade organization, and Shipman & Goodwin LLP, one of Connecticut's largest law firms, are pleased to announce that Reid Waldman, M.D., has received the Entrepreneur of the ...

Talk Online Education Group (51Talk or the Company) (NYSE American: COE), a global online education platform with core ...

Thank you, Governor Pan and Mayor Gong, for your kind remarks; warm welcome to former Governor Zhou—always a great pleasure to see you; and a very good morning to all.

Eczema, a chronic inflammatory skin condition, significantly impacts patients’ quality of life through persistent itching and ...

Contango ORE, Inc. ("Contango" or the "Company") and Dolly Varden Silver Corporation ("Dolly Varden") are pleased to announce that they have entered into an arrangement agreement (the "Arrangement ...